Gene · 2237
Papers3,948
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,161 to 1,180 of 3,948
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of a gene signature associated with iron metabolism in lung adenocarcinoma. | Bioengineered | 2021 | 34323652 | PubTator, text mining | PubMed |
| {BiW8 O30 } Exerts Antitumor Effect by Triggering Pyroptosis and Upregulating Reactive Oxygen Species. | Angew Chem Int Ed Engl | 2021 | 34314545 | PubTator, text mining | PubMed |
| The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma. | Front Oncol | 2021 | 34307148 | PubTator, text mining | PubMed |
| The Instability of Dimeric Fc-Fusions Expressed in Plants Can Be Solved by Monomeric Fc Technology. | Front Plant Sci | 2021 | 34305971 | PubTator, text mining | PubMed |
| The first queen-worker association for Cretaceous Formicidae: the winged caste of Haidomyrmex cerberus. | Zookeys | 2021 | 34305419 | PubTator, text mining | PubMed |
| A high-specificity flap probe-based isothermal nucleic acid amplification method based on recombinant FEN1-Bst DNA polymerase. | Biosens Bioelectron | 2021 | 34303138 | PubTator, text mining | PubMed |
| LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancer. | Genes Genomics | 2021 | 34302635 | PubTator, text mining | PubMed |
| Exploiting DNA Damage Repair in Precision Cancer Therapy: BRCA1 as a Prime Therapeutic Target. | Cancers (Basel) | 2021 | 34298653 | PubTator, text mining | PubMed |
| The role of non-coding RNAs in drug resistance of oral squamous cell carcinoma and therapeutic potential. | Cancer Commun (Lond) | 2021 | 34289530 | PubTator, text mining | PubMed |
| MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L-like during epithelial-mesenchymal transition. | Cancer Sci | 2021 | 34286904 | PubTator, text mining | PubMed |
| Understanding APE1 cellular functions by the structural preference of exonuclease activities. | Comput Struct Biotechnol J | 2021 | 34285771 | PubTator, text mining | PubMed |
| AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis. | Int J Gen Med | 2021 | 34285555 | PubTator, text mining | PubMed |
| Capillarized Liver Sinusoidal Endothelial Cells Undergo Partial Endothelial-Mesenchymal Transition to Actively Deposit Sinusoidal ECM in Liver Fibrosis. | Front Cell Dev Biol | 2021 | 34277612 | PubTator, text mining | PubMed |
| Identification of Flap Endonuclease 1 With Diagnostic and Prognostic Value in Breast Cancer. | Front Oncol | 2021 | 34277392 | PubTator, text mining | PubMed |
| Adenomatous polyposis coli in cancer and therapeutic implications. | Oncol Rev | 2021 | 34267890 | PubTator, text mining | PubMed |
| The mechanism of gap creation by a multifunctional nuclease during base excision repair. | Sci Adv | 2021 | 34261654 | PubTator, text mining | PubMed |
| Cytokine Consistency Between Bone Marrow and Peripheral Blood in Patients With Philadelphia-Negative Myeloproliferative Neoplasms. | Front Med (Lausanne) | 2021 | 34249954 | PubTator, text mining | PubMed |
| Function and clinical significance of N6-methyladenosine in digestive system tumours. | Exp Hematol Oncol | 2021 | 34246319 | PubTator, text mining | PubMed |
| Upregulating KTN1 promotes Hepatocellular Carcinoma progression. | J Cancer | 2021 | 34234850 | PubTator, text mining | PubMed |
| Overexpression of HPRT1 is associated with poor prognosis in head and neck squamous cell carcinoma. | FEBS Open Bio | 2021 | 34231338 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2237/papers?page=59